Company Overview
Snapshot
Founded in January 2020 by Omer Zarchi and Nir Zarchi, Nervio operates with 11–50 employees. The company has raised $6.75M across two funding rounds from Merchavia Holdings and eHealth Ventures. In December 2024, Nervio received a grant from the Israel Innovation Authority.
Business overview
Nervio is a digital health startup that applies data science and artificial intelligence to neurophysiology. The company develops an AI-powered neuromonitoring solution designed to prevent avoidable paralysis and severe neurological complications during surgeries. This technology provides real-time alerts to clinicians in the operating room, aiming to minimize permanent nerve injuries. Nervio operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support, serving healthcare providers in North America and Europe.
Strategic signal
In December 2024, Nervio appointed Dr. Richard Vogel as its U.S. CEO, signaling a strategic expansion into the U.S. market. This move, coupled with a post-Seed funding round and a grant from the Israel Innovation Authority, indicates the company's intent to scale its AI-based neurophysiologist support systems to meet the increasing demand for spine surgeries, which are projected to rise by 40% over the next decade. This expansion and leadership appointment suggest a strong growth trajectory and a commitment to addressing critical workforce challenges in neurophysiological monitoring.
Log in to access full profile ›Company Intelligence Q&A
- What significant leadership appointment did Nervio make recently?
- In December 2024, Nervio appointed Dr. Richard Vogel as its U.S. CEO. This appointment is part of the company's strategy to expand its operations in the United States.
- What was the purpose of Nervio's grant from the Israel Innovation Authority?
- In December 2024, Nervio received a grant from the Israel Innovation Authority to support its AI-based neurophysiologist support systems, aiding in the company's expansion and technological development.
- What was Nervio's total capital raised?
- Nervio has raised a total of $6.75M across two funding rounds from Merchavia Holdings and eHealth Ventures.
- Which program did Nervio participate in during July 2023?
- In July 2023, Nervio was selected for the second cohort of Assuta Medical Center's 'RISE with US' program, which connects startups to the global healthcare market, with a focus on the American market.
- When was Nervio founded and by whom?
- Nervio was founded in January 2020 by Omer Zarchi and Nir Zarchi.